Cesaro A - Search Results

1

Effects of human antimicrobial cryptides identified in apolipoprotein B depend on specific features of bacterial strains.

Gaglione R, Cesaro A, Dell'Olmo E, Della Ventura B, Casillo A, Di Girolamo R, Velotta R, Notomista E, Veldhuizen EJA, Corsaro MM, De Rosa C, Arciello A. Gaglione R, et al. Among authors: cesaro a. Sci Rep. 2019 Apr 30;9(1):6728. doi: 10.1038/s41598-019-43063-3. Sci Rep. 2019. PMID: 31040323 Free PMC article.

2

Cryptides Identified in Human Apolipoprotein B as New Weapons to Fight Antibiotic Resistance in Cystic Fibrosis Disease.

Gaglione R, Cesaro A, Dell'Olmo E, Di Girolamo R, Tartaglione L, Pizzo E, Arciello A. Gaglione R, et al. Among authors: cesaro a. Int J Mol Sci. 2020 Mar 17;21(6):2049. doi: 10.3390/ijms21062049. Int J Mol Sci. 2020. PMID: 32192076 Free PMC article.

3

Host defence peptides identified in human apolipoprotein B as promising antifungal agents.

Dell'Olmo E, Gaglione R, Cesaro A, Cafaro V, Teertstra WR, de Cock H, Notomista E, Haagsman HP, Veldhuizen EJA, Arciello A. Dell'Olmo E, et al. Among authors: cesaro a. Appl Microbiol Biotechnol. 2021 Mar;105(5):1953-1964. doi: 10.1007/s00253-021-11114-3. Epub 2021 Feb 12. Appl Microbiol Biotechnol. 2021. PMID: 33576886 Free PMC article.

4

Host defense peptides identified in human apolipoprotein B as novel food biopreservatives and active coating components.

Dell'Olmo E, Gaglione R, Sabbah M, Schibeci M, Cesaro A, Di Girolamo R, Porta R, Arciello A. Dell'Olmo E, et al. Among authors: cesaro a. Food Microbiol. 2021 Oct;99:103804. doi: 10.1016/j.fm.2021.103804. Epub 2021 Apr 12. Food Microbiol. 2021. PMID: 34119097

5

Impact of a Single Point Mutation on the Antimicrobial and Fibrillogenic Properties of Cryptides from Human Apolipoprotein B.

Gaglione R, Smaldone G, Cesaro A, Rumolo M, De Luca M, Di Girolamo R, Petraccone L, Del Vecchio P, Oliva R, Notomista E, Pedone E, Arciello A. Gaglione R, et al. Among authors: cesaro a. Pharmaceuticals (Basel). 2021 Jun 29;14(7):631. doi: 10.3390/ph14070631. Pharmaceuticals (Basel). 2021. PMID: 34209895 Free PMC article.

6

Synthetic Antibiotic Derived from Sequences Encrypted in a Protein from Human Plasma.

Cesaro A, Torres MDT, Gaglione R, Dell'Olmo E, Di Girolamo R, Bosso A, Pizzo E, Haagsman HP, Veldhuizen EJA, de la Fuente-Nunez C, Arciello A. Cesaro A, et al. ACS Nano. 2022 Feb 22;16(2):1880-1895. doi: 10.1021/acsnano.1c04496. Epub 2022 Feb 3. ACS Nano. 2022. PMID: 35112568

7

Loading of Polydimethylsiloxane with a Human ApoB-Derived Antimicrobial Peptide to Prevent Bacterial Infections.

De Luca M, Gaglione R, Della Ventura B, Cesaro A, Di Girolamo R, Velotta R, Arciello A. De Luca M, et al. Among authors: cesaro a. Int J Mol Sci. 2022 May 7;23(9):5219. doi: 10.3390/ijms23095219. Int J Mol Sci. 2022. PMID: 35563610 Free PMC article.

8

Novel Retro-Inverso Peptide Antibiotic Efficiently Released by a Responsive Hydrogel-Based System.

Cesaro A, Gaglione R, Chino M, De Luca M, Di Girolamo R, Lombardi A, Filosa R, Arciello A. Cesaro A, et al. Biomedicines. 2022 Jun 2;10(6):1301. doi: 10.3390/biomedicines10061301. Biomedicines. 2022. PMID: 35740323 Free PMC article.

9

Methods for the design and characterization of peptide antibiotics.

Cesaro A, Torres MT, de la Fuente-Nunez C. Cesaro A, et al. Methods Enzymol. 2022;663:303-326. doi: 10.1016/bs.mie.2021.11.003. Epub 2021 Dec 28. Methods Enzymol. 2022. PMID: 35168794 Review.

10

Antibiotic failure: Beyond antimicrobial resistance.

de la Fuente-Nunez C, Cesaro A, Hancock REW. de la Fuente-Nunez C, et al. Among authors: cesaro a. Drug Resist Updat. 2023 Nov;71:101012. doi: 10.1016/j.drup.2023.101012. Epub 2023 Oct 18. Drug Resist Updat. 2023. PMID: 37924726 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page